Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - atenolol, quantity: 50 mg - tablet, film coated - excipient ingredients: magnesium carbonate hydrate; sodium starch glycollate type a; colloidal anhydrous silica; maize starch; sodium lauryl sulfate; magnesium stearate; purified water; hypromellose; macrogol 6000; titanium dioxide; purified talc - atenolol is indicated in the management of:,(i) all grades of hypertension, including hypertension of renal origin. (ii) frequent disabling angina without evidence of cardiac failure. (iii) cardiac arrhythmias (acute treatment of supraventricular and ventricular arrhythmias including those associated with acute myocardial infarction), (iv) myocardial infarction - late intervention (beta-blocker class effect greater than 12 hours after onset of chest pain)

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - atenolol, quantity: 50 mg - tablet, film coated - excipient ingredients: magnesium carbonate hydrate; sodium starch glycollate type a; colloidal anhydrous silica; maize starch; sodium lauryl sulfate; magnesium stearate; purified water; hypromellose; macrogol 6000; titanium dioxide; purified talc - atenolol is indicated in the management of:,(i) all grades of hypertension, including hypertension of renal origin. (ii) frequent disabling angina without evidence of cardiac failure. (iii) cardiac arrhythmias (acute treatment of supraventricular and ventricular arrhythmias including those associated with acute myocardial infarction), (iv) myocardial infarction - late intervention (beta-blocker class effect greater than 12 hours after onset of chest pain)

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - atenolol, quantity: 25 mg - tablet, film coated - excipient ingredients: magnesium carbonate hydrate; sodium starch glycollate type a; colloidal anhydrous silica; maize starch; sodium lauryl sulfate; magnesium stearate; purified water; hypromellose; macrogol 6000; titanium dioxide; purified talc - atenolol is indicated in the management of:,(i) all grades of hypertension, including hypertension of renal origin. (ii) frequent disabling angina without evidence of cardiac failure. (iii) cardiac arrhythmias (acute treatment of supraventricular and ventricular arrhythmias including those associated with acute myocardial infarction), (iv) myocardial infarction - late intervention (beta-blocker class effect greater than 12 hours after onset of chest pain)

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - atenolol, quantity: 25 mg - tablet, film coated - excipient ingredients: magnesium carbonate hydrate; sodium starch glycollate type a; colloidal anhydrous silica; maize starch; sodium lauryl sulfate; magnesium stearate; purified water; hypromellose; macrogol 6000; titanium dioxide; purified talc - atenolol is indicated in the management of:,(i) all grades of hypertension, including hypertension of renal origin. (ii) frequent disabling angina without evidence of cardiac failure. (iii) cardiac arrhythmias (acute treatment of supraventricular and ventricular arrhythmias including those associated with acute myocardial infarction), (iv) myocardial infarction - late intervention (beta-blocker class effect greater than 12 hours after onset of chest pain)

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - atenolol, quantity: 5 mg/ml - oral liquid, solution - excipient ingredients: propylene glycol; propyl hydroxybenzoate; saccharin sodium; purified water; citric acid monohydrate; sorbitol solution (70 per cent) (non-crystallising); sodium citrate dihydrate; methyl hydroxybenzoate; flavour - all grades of hypertension including hypertension of renal origin.,frequent disabling angina without evidence of cardiac failure,cardiac arrhythmias (acute treatment of supraventricular and ventricular arrhythmias including those with acute myocardial infarction),myocardial infarction - late intervention (beta-blocker class effect greater than 12 hours after onset of chest pain)

Малта - Енглески - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - hydrochlorothiazide, losartan potassium - film-coated tablet - hydrochlorothiazide 12.5 mg losartan potassium 50 mg - agents acting on the renin-angiotensin system

Малта - Енглески - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - hydrochlorothiazide, losartan potassium - film-coated tablet - hydrochlorothiazide 12.5 mg losartan potassium 100 mg - agents acting on the renin-angiotensin system

Малта - Енглески - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - hydrochlorothiazide, losartan potassium - film-coated tablet - hydrochlorothiazide 25 mg losartan potassium 100 mg - agents acting on the renin-angiotensin system

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

syri limited, t/a thame laboratories - atenolol - oral solution - 5 mg/ml - atenolol - beta-blocking agents, plain, selective - management of hypertension management of angina management of cardiac arrhythmias myocardial infarction. early intervention in the acute phase

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - atenolol -